CF PharmTech, Inc. filed a next day disclosure return with HKEX reporting a share repurchase on 24 February 2026. The company bought back 27,000 H shares on the Exchange at a volume-weighted average price of HKD 36.9422 per share (HKD 36.60–37.18), for an aggregate consideration of HKD 997,440, and held the shares as treasury shares.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260224-12028633), on February 24, 2026, and is solely responsible for the information contained therein.
Comments